In summary, the upregulation of mitophagy activators in serum and CSF and downregulation of TFEB in serum of AD patients with dementia indicate impairment in autophagy-lysosomal pathway degradation and suggest that dysregulation of autophagy/mitophagy plays a significant role in onset and progression of AD. This evidence concerns the gene TFEB and Alzheimer disease.